3 news items
Ligand Pharmaceuticals Announces Launch Of Pelthos Therapeutics To Accelerate Commercialization Of ZELSUVMI, Scott Plesha Named CEO
LGND
3 Apr 24
is committed to commercializing innovative, safe, and efficacious therapeutic products to help patients impacted by diseases with limited treatment options
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMIâ„¢
LGND
3 Apr 24
(Photo: Business Wire)
Pelthos is committed to commercializing innovative, safe, and efficacious
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
AAN
AHCO
ALPP
27 Feb 24
/share together with investor commitment for additional $1 million.
Thoughtworks Holding, Inc
- Prev
- 1
- Next